Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

An Inborn Variation In The Anaplastic Lymphoma Receptor Tyrosine Kinase Gene ( ALK ) Increases Risk Of MAF (Musculoaponeurotic Fibrosarcoma Oncogene Homolog) High Expressing Myeloma

Annette Juul Vangsted, MD, Stephen Erickson, Ph.D, Naveen Sanath Kumar, MD, Elizabeth Ann Coleman, PhD, Erming Tian, PhD, Julia Goodwin, PhD, Joshua Epstein, DSc, Owen Stephens, Ph.D., Bart Barlogie, MD, PhD, Christoph Heuck, MD

Blood (2013) 122 (21): 1908.

https://doi.org/10.1182/blood.V122.21.1908.1908

Published: 2013

Journal Articles

Chemotherapy-Induced Oral Mucositis: 11 SNPs Implicated In GWAS Of 972 Patients With Multiple Myeloma

Elizabeth Ann Coleman, PhD, Jeannette Y Lee, Ph.D., Stephen Erickson, Ph.D, Julia Goodwin, PhD, Marjorie Beggs, PhD, Naveen Sanathkumar, MD, Daohong Zhou, MD, Kent McKelvey, MD, Vinay Raj, Ph.D., Senu Apewokin, MD, Owen Stephens, Ph.D., Carol Enderlin, Ph.D., Annette Juul Vangsted, MD, Patty Reed, MS, Elias J. Anaissie, MD

Blood (2013) 122 (21): 3316.

https://doi.org/10.1182/blood.V122.21.3316.3316

Published: 2013

Journal Articles

Prediction of cytogenetic abnormalities with gene expression profiles

Yiming Zhou, Qing Zhang, Owen Stephens, Christoph J. Heuck, Erming Tian, Jeffrey R. Sawyer, Marie-Astrid Cartron-Mizeracki, Pingping Qu, Jason Keller, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2012) 119 (21): e148–e150.

https://doi.org/10.1182/blood-2011-10-388702

Published: 2012

Includes: Supplemental data

Journal Articles

Prediction of Cytogenetic Abnormalities in Multiple Myeloma Based on Gene Expression Profiles

Yiming Zhou, PhD, Qing Zhang, PhD, Christoph Heuck, MD, Owen Stephens, Erming Tian, PhD, Jeffrey Sawyer, PhD, Marie-Astrid Cartron-Mizeracki, MS, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD

Blood (2011) 118 (21): 629.

https://doi.org/10.1182/blood.V118.21.629.629

Published: 2011

Journal Articles

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4 , as novel high-risk feature in myeloma treated with Total Therapy 3

John D. Shaughnessy, Jr, Pingping Qu, Saad Usmani, Christoph J. Heuck, Qing Zhang, Yiming Zhou, Erming Tian, Ichiro Hanamura, Frits van Rhee, Elias Anaissie, Joshua Epstein, Bijay Nair, Owen Stephens, Ryan Williams, Sarah Waheed, Yazan Alsayed, John Crowley, Bart Barlogie

Blood (2011) 118 (13): 3512–3524.

https://doi.org/10.1182/blood-2010-12-328252

Published: 2011

Includes: Supplemental data

Journal Articles

High-Risk Multiple Myeloma Is Characterized by Uniform Over-Expression of Mirnas and Increased Copy Number and Expression of Argonaute 2 , A Master Regulator of Mirna Maturation and B-Cell Development.

Yiming Zhou, Lijuan Chen, Bart Barlogie, MD, PhD, Owen Stephens, PhD, Xiaosong Wu, PhD, David Williams, PhD, Marie-astrid Cartron, PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, Sarah Waheed, MD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, MD, PhD, Elias Anaissie, MD, PhD, John D Shaughnessy, Jr.

Blood (2009) 114 (22): 1804.

https://doi.org/10.1182/blood.V114.22.1804.1804

Published: 2009

Journal Articles

Integration of DNA Copy Number and Gene Expression Alterations Reveal Novel Insights into the Molecular Pathogenesis and Prognosis of Multiple Myeloma

Yiming Zhou, PhD, Bart Barlogie, MD, PhD, Damir Herman, PhD, Owen Stephens, PhD, Erming Tian, PhD, David Williams, PhD, Marie-astrid Cartron, PhD, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, MD, PhD, Elias Anaissie, MD, PhD, Jeffrey Sawyer, Ph.D., John D. Shaughnessy, Jr., PhD

Blood (2008) 112 (11): 250.

https://doi.org/10.1182/blood.V112.11.250.250

Published: 2008

Journal Articles

Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy

John D. Shaughnessy, Jr., PhD, Pingping Qu, MD, Ricky Edmondson, PhD, Damir Herman, PhD, Yiming Zhou, PhD, Erming Tian, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, Elias Anaissie, Ya-wei Qiang, Joshua Epstein, PhD, Shmuel Yaccoby, PhD, David Williams, Fenghuang Zhan, PhD, Owen Stephens, Antje Hoering, PhD, John Crowley, PhD, Bart Barlogie, MD, PhD

Blood (2008) 112 (11): 733.

https://doi.org/10.1182/blood.V112.11.733.733

Published: 2008

Journal Articles

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

Ya-Wei Qiang, Yu Chen, Owen Stephens, Nathan Brown, Bangzheng Chen, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2008) 112 (1): 196–207.

https://doi.org/10.1182/blood-2008-01-132134

Published: 2008

Journal Articles

Genetic Polymorphisms Identify the Likelihood of Bone Disease in Myeloma: Correlations with Myeloma Cell DKK1 Expression and High Risk Gene Signatures.

Brian G.M. Durie, MD, Brian Van Ness, PhD, Christine Ramos, PhD, Owen Stephens, Majda Haznadar, Antje Hoering, PhD, Jeff Haessler, PhD, Michael S. Katz, BS, Gregory R. Mundy, MD, Robert A. Kyle, MD, Gareth J. Morgan, MD, PhD, John Crowley, PhD, Bart Barlogie, MD, John Shaughnessy, Jr., PhD

Blood (2007) 110 (11): 816.

https://doi.org/10.1182/blood.V110.11.816.816

Published: 2007

Journal Articles

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

Simona Colla, Fenghuang Zhan, Wei Xiong, Xiaosong Wu, Hongwei Xu, Owen Stephens, Shmuel Yaccoby, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2007) 109 (10): 4470–4477.

https://doi.org/10.1182/blood-2006-11-056747

Published: 2007

Journal Articles

NSC 338258 Represents a Novel Anti-Neoplastic Agent for the Treatment of Multiple Myeloma.

Erming Tian, Terry Landowski, Owen Stephens, Shmuel Yaccoby, Bart Barlogie, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3469.

https://doi.org/10.1182/blood.V108.11.3469.3469

Published: 2006

Journal Articles

On the Molecular Mechanism of DKK1 Inhibition of Osteoblast Differentiation in Multiple Myeloma.

Ya-Wei Qiang, Yu Chen, Owen Stephens, Jeff Rubin, Stuart Rudikoff, Bart Barlogie, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3429.

https://doi.org/10.1182/blood.V108.11.3429.3429

Published: 2006

Journal Articles

Beta-Catenin and N-Cadherin in Myeloma: Implications for Adhesion and Migration.

Fenghuang Zhan, MD, PhD, Simona Colla, PhD, Ya-Wei Qiang, MD, PhD, Owen Stephens, BS, Yongsheng Huang, MS, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 2497.

https://doi.org/10.1182/blood.V106.11.2497.2497

Published: 2005

Journal Articles

The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.

Erming Tian, BS, Owen Stephens, BS, Susan Holbeck, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 3379.

https://doi.org/10.1182/blood.V106.11.3379.3379

Published: 2005

Journal Articles

The Gene Expression Signatures (GEP) of Whole Bone Marrow Biopsies (Bx) from Patients with Multiple Myeloma (MM) in Remission Reflect Disease Risk and Therapy.

Fenghuang Zhan, MD, PhD, Yongsheng Huang, MS, Rudy Van Hemert, MD, Owen Stephens, BS, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 1547.

https://doi.org/10.1182/blood.V106.11.1547.1547

Published: 2005

NARROW

An Inborn Variation In The Anaplastic Lymphoma Receptor Tyrosine Kinase Gene ( ALK ) Increases Risk Of MAF (Musculoaponeurotic Fibrosarcoma Oncogene Homolog) High Expressing Myeloma

Chemotherapy-Induced Oral Mucositis: 11 SNPs Implicated In GWAS Of 972 Patients With Multiple Myeloma

Prediction of cytogenetic abnormalities with gene expression profiles

Prediction of Cytogenetic Abnormalities in Multiple Myeloma Based on Gene Expression Profiles

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4 , as novel high-risk feature in myeloma treated with Total Therapy 3

High-Risk Multiple Myeloma Is Characterized by Uniform Over-Expression of Mirnas and Increased Copy Number and Expression of Argonaute 2 , A Master Regulator of Mirna Maturation and B-Cell Development.

Integration of DNA Copy Number and Gene Expression Alterations Reveal Novel Insights into the Molecular Pathogenesis and Prognosis of Multiple Myeloma

Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

Genetic Polymorphisms Identify the Likelihood of Bone Disease in Myeloma: Correlations with Myeloma Cell DKK1 Expression and High Risk Gene Signatures.

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

NSC 338258 Represents a Novel Anti-Neoplastic Agent for the Treatment of Multiple Myeloma.

On the Molecular Mechanism of DKK1 Inhibition of Osteoblast Differentiation in Multiple Myeloma.

Beta-Catenin and N-Cadherin in Myeloma: Implications for Adhesion and Migration.

The Ellipticine Derivative NSC 338258 Has Anti-Myeloma Activity.

The Gene Expression Signatures (GEP) of Whole Bone Marrow Biopsies (Bx) from Patients with Multiple Myeloma (MM) in Remission Reflect Disease Risk and Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only